Deng et al. discovered that the expression of HAX-1 is high in glioma samples and lineage cells and is related to the clinicopathology features and prognoses of glioma; moreover, it promotes the proliferation of glioblastoma cells and inhibits tumor cell apoptosis. This evidence concerns the gene HAX1 and central nervous system cancer.